Iron Deficiency Anaemia in Adult Patients with Inflammatory Bowel Disease
Blood and Nutrition
Ferric maltol 30mg capsules (Feraccru®) are not recommended for the treatment of iron deficiency anaemia (IDA) in patients with inflammatory bowel disease (IBD) in the Lancashire and South Cumbria health economies. Further studies assessing the efficacy, safety and cost-effectiveness of ferric maltol versus other iron formulations are required to demonstrate the position of ferric maltol in the treatment pathway of IDA in patients with IBD.
Reason for decision:
Not recommended for prescribing on the NHS in Lancashire & South Cumbria